magnesium-trisilicate has been researched along with ferrous-sulfate* in 2 studies
2 other study(ies) available for magnesium-trisilicate and ferrous-sulfate
Article | Year |
---|---|
The preservation of some oral liquid preparations. The replacement of chloroform by other preservatives.
Chloroform should be considered as an obsolete preservative for pharmaceutical preparations, because of its toxicological implications and its physical instability. The effectiveness of possible alternatives for chloroform in three oral liquid pharmaceutical preparations was investigated, using a microbiological challenge test. Magnesium trisilicate mixture (British Pharmacopoeia) can be adequately preserved with methylparaben (2 g/l). Only insignificant amounts of methylparaben were absorbed by the solids present in the magnesium trisilicate mixture. Ferrous sulfate mixture (British Pharmacopoeia) can be preserved with a mixture of methylparaben (1.8 g/l) and propylparaben (0.2 g/l). Sorbic acid (1 g/l) is a suitable preservative for promethazine hydrochloride syrup. Topics: Administration, Oral; Bacteria; Chloroform; Dosage Forms; Drug Contamination; Drug Stability; Drug Storage; Ferrous Compounds; Fungi; Magnesium Silicates; Microbial Sensitivity Tests; Parabens; Preservatives, Pharmaceutical; Promethazine; Sorbic Acid | 1994 |
Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics.
Following recent concern over probable interactions between the 4-quinolones and metal ions, the effect of co-administered drugs--sodium bicarbonate, potassium citrate, ferrous sulphate, magnesium trisilicate, calcium carbonate and aluminium hydroxide--on the saliva and urine pharmacokinetics of ofloxacin in healthy human volunteers has been investigated. The Cmax and AUC0-9 in saliva were generally in the range 1.05-1.40 mg/L and 4.89-6.16 mg.h/L, respectively, and were unaffected (P less than 0.05) by the metallic drugs, except aluminium hydroxide which lowered these values. Again, only aluminium hydroxide modified the Ka of ofloxacin, resulting in a slower absorption rate. However, none of the metallic drugs altered the T1/2 beta of the 4-quinolone in saliva. In-vitro studies using simulated gastric fluid showed that ferrous sulphate, aluminium hydroxide and calcium carbonate reduced ofloxacin availability to 67.4%, 69.3% and 73.8%, respectively. This effect was ascribed to the formation of complexes between ofloxacin and the metal ions concerned. Substantial correlation between in-vitro and in-vivo availability data was demonstrated in all cases except for ofloxacin combinations with ferrous sulphate and calcium carbonate. In general, there was also good correlation between the saliva and urine data. Topics: Adult; Aluminum Hydroxide; Bicarbonates; Biological Availability; Calcium Carbonate; Citrates; Citric Acid; Drug Interactions; Ferrous Compounds; Humans; Magnesium; Magnesium Silicates; Male; Metals; Ofloxacin; Saliva; Silicic Acid; Sodium; Sodium Bicarbonate | 1991 |